Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Galapagos NV €296.2 Million Follow-On Offering of American Depositary Shares
Davis Polk advised the representatives of the several underwriters in connection with Galapagos NV’s offering of 2,961,373…
Davis Polk Advises Roche Holdings on Its $1.4 Billion Notes Offering
Davis Polk advised Roche Holdings, Inc. in connection with its Rule 144A/Regulation S offering of $750 million aggregate…
Halfmoon Parent, Inc. $20 Billion Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with an unregistered offering of $20 billion…
Zai Lab Limited $150 Million Follow-On Offering of American Depositary Shares
Davis Polk advised Zai Lab Limited in connection with its first follow-on offering of $150 million of American Depositary…
Illumina, Inc. $750 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Illumina,…
Zoetis Inc. $1.5 Billion Senior Notes Offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Zoetis Inc. of $300…
Davis Polk Advises ViewRay, Inc. on Its $172.5 Million Follow-On Common Stock Offering
Davis Polk advised ViewRay, Inc. in connection with its $172.5 million SEC-registered follow-on offering of 18,648,649…
NeoGenomics Follow-On Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the…
REGENXBIO Inc. $175.5 Million Common Stock Offering
Davis Polk advised the representatives of the underwriters in connection with the $175.5 million offering of 2,700,000…
BeiGene Ltd. HK$7.08 Billion (US$903 Million) Public Offering on the Hong Kong Stock Exchange
Davis Polk advised the underwriters and the joint global coordinators in the public offering of BeiGene, Ltd. on the…